← All trials
NCT00272948
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2005
- Primary completion
- Jan 1, 2009
- Completion date
- Jul 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 360
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- European Group for Blood and Marrow TransplantationLead sponsor
- Jazz PharmaceuticalsCollaborator
- University of UlmOverall official - principal investigator
- Deutsche Krebshilfe e.V.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.